Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here

Explore a partnership with Alloy

How can we help?

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. As a reflection of Alloy’s relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation. We collaborate with our partners to design the best therapeutic campaigns and engagements to meet your pipeline goals. If you are ready to connect with our team in real time to discuss your therapeutic biologics discovery needs, click the button below to schedule a time with us.   

I’D LIKE SOMEONE FROM BUSINESS DEVELOPMENT TO FOLLOW UP OVER EMAIL

If you’d rather hear from someone over email, please complete our form and we will be in touch shortly.

I’d like someone from business development to follow up over email
I’d like more material about Alloy Antibody Discovery Services
I’d like more material about Keyway TCR Discovery
I’d like to join the Alloy Mailing List

Step 1 of 3

  • Choose from below and complete our form.

Please describe your interest in Alloy

How can we help?

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. As a reflection of Alloy’s relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation.

I’D LIKE SOMEONE FROM BUSINESS DEVELOPMENT TO FOLLOW UP OVER EMAIL

Complete our form and someone will be in touch shortly.

Please describe your interest in Alloy

Partnerships at Work

Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, genetic medicines, peptides, cell therapies, and drug delivery. Partners may access all current and future technologies through a discovery service relationship or for a flat annual fee through Alloy’s Innovation Subscriptions offering. Read our recent announcements below to learn how we collaborate with our partners. 

read more partnership announcements
See our partnerships in action in the Media

Case Studies

Learn how we partner with the global drug discovery community to help them advance the best drug candidates.

Targeting GPCRs with DeepImmune Antibody Discovery

Access the white paper

Thanks for your interest in our white paper, Targeting GPCRs with DeepImmune Antibody Discovery. 

G protein-coupled receptors (GPCRs) play a central role in multiple physiological functions, from endocrine sensing to neurotransmission to chemotaxis of immune cells. This class has long been an attractive target for novel antibody drug discovery campaigns in multiple disease indications, but their unique nature produces many challenges for in vivo antibody discovery. In this white paper, we detail how our humanized mouse discovery platform, the ATX-Gx™, have been successfully utilized for GPCR-targeted antibody discovery, Alloy’s DeepImmune™ Antibody Discovery service builds on this robust in vivo discovery platform, coupling best-in-class immunogen production with multiple binder recovery approaches, and advanced machine-learning-based techniques for lead identification and optimization. 

asdf

Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please read and Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound